Symptoms in the cancer patient - Of importance for their caregivers’ quality of life and mental health? by Valeberg, Berit Taraldsen & Grov, Ellen Karine
1 
 
 
 
Symptoms in the cancer patient –  
of importance for their caregivers’ quality of life and mental 
health?  
 
Berit Taraldsen Valeberg, CRNA, MSc, PhDa♣*, Ellen Karine Grov, RN, MSc, PhDb♣  
 
a Oslo University College, Department of Nursing, Oslo, Norway 
b Buskerud University College, Department of Health Science, Drammen, Norway & 
Sogn og Fjordane University College, Faculty of Health Science, Førde, Norway 
♣ Equal contributors.  
 
*Corresponding author:   
Berit Taraldsen Valeberg, MNSc, PhD, 
Oslo University College, Department of Nursing,  
Oslo, Norway 
Phone: +47 22453835             
Fax: +47 22 453855 
 
E-mail: berit.valeberg@hioa.no 
 
Subtitle: Cancer patients’ symptoms affecting caregivers’ quality of life and mental health 
2 
 
 
Symptoms in the cancer patient – of importance for their caregivers’ quality of life and 
mental health?  
Purpose: To examine the level of symptom burden in a sample of cancer patients in a 
curative and palliative phase. In addition to determine a) whether the patients’ symptom 
burden and patients’ demographic variables, and b) the caregivers’ demographic variables’ 
impact on the caregivers’ quality of life and mental health.  
Method: This descriptive, cross-sectional study combines data from two samples. The first 
group consists of caregivers of hospitalized patients with cancer in the late palliative phase 
and the second group is caregivers of outpatients with cancer who have pain and/or use of 
analgesics.   
Results: The main result showed that the symptom burden was close to equal when we 
compared the cancer patients in the palliative and the curative phase respectively.  The whole 
sample of patients seemed extremely tired because they score high on items capturing fatigue 
or weakness. They also had problems with pain and constipation. For patients having trouble 
sleeping, the caregivers’ reported higher level of depression, whilst caregivers’ gender had 
impact on the caregivers’ anxiety. The younger the patients the more impact on caregivers’ 
QOL mental health.   
Conclusion: In this study no significant differences were revealed when comparing symptom 
burden among cancer patients in different stages of the disease. Caregivers reported more 
depression when patients had trouble sleeping and more declined mental quality of life when 
patients were younger. Female caregivers reported more anxiety than male caregivers. 
 
Key words:  Patient symptoms, cancer, caregivers, quality of life, mental health  
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Introduction 
Caregivers of cancer patients are suggested to be affected by different factors regarding their 
health and well-being during the patient’s disease trajectory (Weitzner et al., 1999; Grunfeld 
et al., 2004; Grov et al., 2006a). The caregivers may be defined as partners, close relatives, 
next-of-kin, and significant others depending on their relationship to the patient (McClement 
et al., 1998).  According to the Norwegian legal definition (Patient’s right law, §3-3), the 
primary caregiver (caregiver) is the one defined by the patient regardless of their family 
connection. The caregivers are to be informed about the patient’s health condition when the 
patient wants to share such information.  
Cancer patients may experience multiple disease or treatment related symptoms 
(Donnelly, 1995).  In a study of 796  consecutive patients with advanced cancer the most 
prevalent symptoms (≥50 %) were pain, easy fatigue, anorexia, weakness, lack of energy, dry 
mouth, dyspnoea, constipation, and early satiety. Most of these symptoms did not differ 
between primary cancer sites in either prevalence or severity. They were not able to correlate 
symptoms with disease stage or separate treatment related symptoms from cancer related 
symptoms (Kirkova et al., 2011a).  However, a comprehensive clinical review of cancer 
symptom clusters showed that disease and treatment related symptoms are influenced by 
primary cancer site, disease stage and antitumor treatment (Kirkova et al., 2011b).  
When staying at home with advanced cancer, the patient and his/her caregiver 
coordinates the support needs necessary in collaboration with the community oncology nurse. 
The impact of the involvement and responsibility during the cancer journey might leave 
concerns on caregivers. Studies have been performed during different stages of the cancer 
patients’ disease trajectory, and for caregivers there are reported burden (Given et al., 2004; 
Goldstein et al., 2004; Doorenbos et al., 2007; Higginson et al., 2008), reaction in terms of 
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particular burden and well-being (McCorkle et al., 1993; Nijboer et al., 1999; Hagedoorn et 
al., 2002; Grov et al., 2006c), quality of life (QOL) (Grov, 2005; Clark, 2006; Grov et al., 
2006b), mental health (Edwards et al., 2004; Grov, 2005) , and a large number of specific 
aspects influencing the caregivers’ situation, e.g. work and economy (Goldzweig et al., 2009), 
and the impact of educational level and educational programs facilitated for caregivers (Clark, 
2006; Goldzweig et al., 2009). In a recent study 38% of caregivers reported depressive 
symptoms in the clinical range as measured by Center for Epidemiological Studies –
Depression scale (CES-D) (Steel et al., 2011).  
Weitzner et al. (1999) compared QOL measured by the Short form 36 (SF-36) in 
caregivers of cancer patients in the palliative versus the curative phase. The caregivers of 
patients in the palliative phase generally reported lower QOL than those caring for patients in 
the curative phase. The latter mentioned study suggested that caregivers’ QOL was dependent 
on factors related to the patient’s condition as well as individual characteristics of the 
caregiver.  The main findings were that caregivers’ physical QOL was dependent on the 
patient’s performance status as well as the education level of the caregivers. They recommend 
research to focus on caregivers’ situation in terms of QOL and emotional distress and factors 
influencing these variables. Others have also stated that the patients’ illness characteristics 
may be factors that influence the families’ level of depression and anxiety (Edwards Clarke, 
2004), and a study of 82 adult caregivers showed that patients’ pain were significantly 
correlated with caregivers’ depression, but they found no correlation between patients’ fatigue 
and caregivers depression (Bush et al., 2004).  
Cancer stage of the patients is shown as a predictor of caregivers’ physical QOL in 
addition to health behaviour and overload (Matthews et al., 2004).  Besides the effect of the 
direct stress or burden of caring for the cancer patients, differences in caregivers’ QOL may 
be linked to gender and partner role expectations.  Stressors that have a strong effect on 
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female family caregivers may have a weaker effect on male family caregivers and vice versa. 
Previous studies have indicated that female caregivers are more distressed by factors 
involving social and family relationships, and male caregivers are more worried about work 
related and financial issues (Goldzweig et al., 2009). Supportiveness, mood and partners’ 
health condition seem to be more sternly related to female caregivers’ than to male 
caregivers’ psychological well-being (Hagedoorn et al., 2002).  
Fridriksdottir et al. (2011) have studied QOL, anxiety, and depression in family 
members of cancer patients and found high prevalence of anxiety and depression. The latter 
mentioned study did not specifically report differences for caregivers when studying patients 
in curative versus palliative phase.  
The curative phase is defined as a stage where the patients are admitted to a curative 
treatment intention, while the palliative phase is defined according to the definition of 
palliative care stated by World Health Organization (WHO) (1990) (WHO (World Health 
Organization) 2005) (http://www.who.int/cancer/palliative/definition/en/) and European 
Association for Palliative Care (EAPC) (2002)(EAPC (European Association for Palliative 
Care) 2005) (http://www.eapcnet.org/about/definition.html). Since Weitzner et al., (1999) 
have reported lower QOL among caregivers of cancer patients in the palliative phase 
compared to those caring for patients in the curative phase, and that explanation for the 
findings might be related to aspects of the patient’s condition as well as individual 
characteristics of the caregivers, we wanted to shed light on the impact of the patients’ 
symptoms and demographic variables in the cancer patients and their caregivers. 
The aims of this study are therefore to examine;  
1) The level of symptom burden in a sample of cancer patients in the curative phase compared 
to the palliative phase  
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2) The impact of patients’ symptom burden, demographic variables of the patients and 
demographic variables of the caregivers on caregivers’ QOL and mental health.  
Since the symptom burden is expected to increase during the cancer trajectory, and the 
symptom load therefore is presumed higher in the palliative than in the curative phase, our 
hypothesis is that the QOL will be affected negatively by patients defined in the palliative 
phase, and those with high symptom load. The same argument is given for the caregivers’ 
mental health, and we expect higher level of anxiety and depression for caregivers of patients 
in the palliative phase and those with high symptom load. In addition we hypothesize that 
female caregivers’ experience higher level of anxiety and depression than men (Hagedoorn et 
al., 2002; Goldzweig et al., 2009). 
Material and methods 
Samples 
This descriptive, cross-sectional study is a secondary analysis which combines data from two 
different studies in which patients were recruited together with their family members. The 
first group of patients were recruited between February 2002 and October 2003. At the 
recruitment time these patients were hospitalized with cancer in the palliative phase staying in 
a large, tertiary referral cancer hospital in Norway, but the intention was to leave the hospital 
for staying at home during this part of the cancer trajectory. All patients had metastatic cancer 
with estimated survival time of < 4 month at the recruitment time. Of the patients recruited to 
this study 31 % died within four month following up and 63 % patients were dead after one 
year (Grov, 2006b).  Eligible patients and family caregivers were consecutively invited to 
participate and given an information letter and a consent form to complete. A total of 96 
dyads consented and completed the questionnaires.  
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The second group of patients was recruited between January and June 2005 from 
outpatient oncology clinics (i.e., general, gynaecology, lung, pain, chemotherapy, 
radiotherapy) at the same hospital as the first patient-group. All patients coming to the 
outpatient clinics during selected periods of time were screened for pain as one of the main 
purposes of the primary study was to describe cancer patients’ pain prevalence (Valeberg et 
al., 2008). Treatment intention (curative or palliative) was assessed from the medical charts 
by an experienced physician. Patients with pain and their family caregivers received written 
information about the study and were invited to participate. A total of 73dyads consented and 
completed the questionnaires and is part of this study.  
Patients in both studies were included if they were: >18 years of age; had a diagnosis 
of cancer; were able to read, write, and understand Norwegian. Patients from the first sample 
had to understand that they had metastatic cancer, have an estimated survival time of more 
than four months, an ECOG performance status ≥ 1, and to be managed at home with support 
from caregivers and/or health care personnel. The exclusion criterion was known mental 
disorder. In the second sample, all patients had self-reported pain of any intensity and/or use 
of analgesics. The recruitment procedure is described more thoroughly elsewhere, for the first 
sample (Grov et al., 2005) and for the second sample (Valeberg et al., 2008).  
All patients and their caregivers provided written informed consent. This study was 
approved by the Regional Ethics Committee, the Norwegian Radium Hospital’s Protocol 
Review Board, and The Norwegian Data Inspectorate.  
Instruments and scoring procedures 
Demographic data from patients included gender, age, marital status (married/partnered or 
not), educational level (primary school (i.e., up to 10 years at school), secondary school (i.e., 
from 11 to 14 years at school), or college/university), and employment status (working full- or 
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part-time or not working). From the caregivers, demographics included age, gender, education 
and work were assessed.  
Medical Record Review  
Patients’ medical records were reviewed by two experienced physicians to obtain 
information on cancer diagnosis, presence of metastasis and whether the treatment intention 
was palliative or curative.  
Functional status  
In the first sample of patients performance status was measured using The Eastern 
Cooperative Oncology Group (ECOG) Performance status assessment tool. The WHO-index 
(ECOG performance status) assesses individual’s status to perform daily activities. It is 
categorized as a score from 0 to 4, (0 = a function of full activity, 1 = with restriction related 
to physically strenuous activity, 2 = capable of self-care, but unable to carry out any work 
activities, up and about more than 50% of waking hours, 3 = capable of only limited self-care, 
confined to bed or chair more than 50% of waking hours, 4 = completely disabled, cannot 
carry out any self- care, totally confined to bed or chair) (Oken et al., 1982).  
Patients in the second sample reported their functional status using a modified 
Karnofsky Performance Status (KPS) scale that ranged from 40 (i.e., disabled, need special 
help and care) to 100 (i.e., adequate health status with no complaints and no evidence of 
disease). Reliability and construct validity of the KPS are well established and it is considered 
to be a global indicator of the functional status of patients with cancer (Schag et al., 1984). In 
order to compare patients from the different settings, patients scoring 80 or higher on the 
Karnofsky scale were labelled as having high function, and patients scoring 40-70 were 
labelled impaired. For ECOG status the cut off was defined to be 0 and 1 to represent high 
function while 2-4 represent impaired.  
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Hospital Anxiety and Depression Scale (HADS)  
Anxiety and depression of caregivers was assessed by the HADS in both samples. The 
HADS has been found to perform well for studying mental health in the general population, in 
cancer patients, and in primary care patients (Mykletun, 2001). The instrument consists of 14 
items, 7 on the depression sub-scale (HADS-D) and 7 on the anxiety sub-scale (HADS-A). 
Each item is scored on a four-point scale from 0 (not present) to 3 (considerable), and the item 
scores are added, giving HADS-D and HADS-A scores from zero (minimum symptom load) 
to 21 (maximum symptom load). A score ≥ 8 - 10 on anxiety or depression is defined as 
borderline abnormal and a score above 10 as abnormal (Zigmond et al., 1983).  
Health Related Quality of Life (QOL): SF-36 
Health related QOL of the caregivers was assessed by SF-36 in both samples. The SF-
36 contains 36 items grouped into the eight multi-item health dimensions including physical 
functioning (PF, 10 items), role limitations due to physical problems (RF, 4 items), bodily 
pain (BP, 2 items), social functioning (SF, 2 items), mental health (MH, 5 items), role 
limitations due to emotional aspects (RE, 3 items), vitality (VT, 4 items), and general health 
perceptions (GH, 5 items) (Ware et al., 1992; Ware J.E. et al., 2000).  The items are answered 
in “yes” or “no” alternatives, or in scales with three to six response alternatives. For each 
dimension questions are coded, summed, and transformed to a scale from zero (worst) to 100 
(best). The SF-36 can also be divided into two component scores, physical and mental health 
sum-scores, named PCS and MCS.  
In order to assess the patient’s condition, eleven items from the EORTC-QLQ-C30 
was used (Aaronson et al., 1993). These conditions are fatigue, pain, nausea and vomiting, 
dyspnea, insomnia, need to rest, weakness, tired, appetite loss, constipation, and diarrhea. 
The conditions are scored from 1 to 4, with higher scores indicating more severe symptoms.  
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Statistical analysis 
Data were analyzed using SPSS Version 17.0 (SPSS, Inc.). Descriptive statistics were 
calculated for the patients’ and family members’ demographics. To examine if patients’ 
disease stage had an impact on the caregivers’ mental health and QOL, the samples were 
divided into caregivers of patients in the palliative phase (n=124) and caregivers of patients in 
the curative phase (n=32).  
The continuous variables were examined with t-tests, and categorical variables with 
χ2-tests, or Fisher’s exact test. Variables that showed a significant difference when comparing 
the groups of patients according to the disease stage (e.g. curative and palliative phase) were 
used further into the regression analysis. Four linear regression analyses were performed with 
the mental and physical health components of the SF 36 and anxiety and depression in the 
family caregivers respectively as the dependent variables. Significance level was set at p < 
.05, and two-sided tests were applied. 
Results 
Demographics patients and family caregiver 
Demographics and clinical characteristics for the patient samples are given in Table 1. The 
patients’ age ranged from 23 to 86 years and the majority was unemployed (or home 
working), married women. When we compared patients in the palliative and curative phase, 
significant differences were found in age, education, cancer sites, and presence of metastases.  
Table 1 approximately here 
The majority of the caregivers were men and their age ranged from 19 to 82 years. About 50 
% of the caregivers worked full time. There are statistically differences between the 
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caregivers of patients in the palliative and curative phase as the family caregivers’ are more 
often older women in the palliative phase (Table 2).  
Table 2 approximately here 
Symptom burden of patients 
Regarding symptoms from EORTC-C30, patients in the curative phase had statistically more 
trouble sleeping than patients in the palliative phase, and patients’ in the palliative phase 
vomited more compared to patients in the curative phase . The highest scores on the 
individual symptoms of the EORTC is “need to rest”, pain, tired, and “felt weak” (Table 3).  
Table 3 approximately here 
The independent variables used in the regression analysis are: caregivers’ age and gender. The 
demographics and clinical variables of the patients are: age, trouble sleeping, vomiting, and 
curative and palliative phase. The palliative phase was identical to ‘the presence of 
metastasis’ and this variable was not brought into the regression analysis to avoid redundancy. 
Linear regression analysis was performed for the physical (PCS), mental (MCS) QOL sum-
scores and anxiety and depression.  For the PCS of the QOL none of the independent 
variables showed significant contribution to the model. For the MCS only the patients’ age 
reached significance. For the anxiety dimension of the HADS, caregivers’ gender revealed 
significant, and for the depression dimension of the HADS, only patients’ report of trouble 
with sleep reached significance.  
Table 4 approximately here 
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Discussion 
The main result of this study was that the symptom burden was close to equal when 
we compared the cancer patients in the palliative and the curative phase respectively. The 
regression analysis showed that patients having trouble sleeping had impact on the caregivers’ 
depression, whilst caregivers’ gender had impact on the caregivers’ anxiety. Women scored 
higher on anxiety than men. For the caregivers’, the mental dimension of QOL showed that 
the patients’ age contributed significantly to the model, the younger the patient the worse 
QOL for the caregivers. 
We expected the symptom burden to be higher for patients in the palliative compared 
to the curative phase, but differences were only found in trouble sleeping and vomiting. An 
explanation for the lack of differences between the two groups may be that the symptom 
burden is the same regardless of where in the cancer trajectory the patients are assessed. 
Symptom burden may be more linked to the treatment and not whether they are considered as 
patients being in a palliative or curative phase. The sample size, especially in the curative 
phase is small, and may not capture the symptom burden present for these patients.  
Patients in the curative phase scored higher on trouble sleeping compared to the 
patients in the palliative phase. The reason for this is not obvious, but one explanation may be 
that the patients in the palliative phase may have adapted to a larger extent to their situation, 
and are more often on medication regulating sleep (Sela et al., 2005) or have learnt to use 
techniques to relax. Patients in the palliative phase vomited more than patients in the curative 
phase. The reason for this is not apparent, but maybe patients in this group are getting 
treatments that have more side-effects than the patients in the curative phase? Unfortunate, we 
do not have available data on the patients’ treatments.  
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The scores on the individual symptoms of the EORTC indicate that the whole sample 
of patients is extremely tired because they score high on the items capturing fatigue or 
weakness. This finding is supported by previous research (Kirkova et al., 2011a; Roscoe, 
2007; Radbruch et al., 2008). In a study of 1,000 patients in an American Palliative care 
Program, 84% of the patients reported fatigue, 66% reported weakness and 61% reported lack 
of energy (Walsh et al., 2000).  
The high value in the patients’ pain score shows that the patients also had problems 
with this symptom. This scoring pattern is also in accordance with finding in previous 
research ( Kirkova et al., 2011 ;Valeberg et al., 2008), but the result may also be attributed to 
the fact that the sample of outpatients were screened for pain when invited to participate in the 
study.  
A previous study from Norway has argued that caregivers of patients in the palliative 
phase have lower scores on the mental dimension on QOL and higher scores on anxiety than 
the general population (Grov et al., 2005). We therefore expected the palliative phase to be 
more challenging for caregivers, suggesting differences between the scorings on the mental 
dimension on QOL and higher anxiety level for caregivers of patients in the palliative than for 
caregivers of patients in the curative phase. We did not find support for that hypothesis. The 
reason for this may be that the palliative and the curative phase are equally stressful or 
challenging. In addition we have to bring into consideration that the definition of curative and 
palliative phase does not capture or differentiate patients’ overall condition in a meaningful 
manner.  
In the regression analysis we brought in variables that showed statistically significant 
differences between patients in the palliative and curative phase. The only demographic 
variable included for the patients was age which revealed significant impact on the mental 
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dimension of QOL for caregivers. A possible reason for this finding may be that the stress and 
burden are higher when a younger relative has advanced cancer. We suggested that the 
scenario of a younger person facing death is harder to take in compared to the fact that an 
older person to a kind of extent is expected to die. In this study the patients’ mean age is 59 
years, so the age might be characterized as ‘middle age’. However, even with a middle age 
patient sample, it seems worse for the caregivers as younger the age of the patient.  
Demographic variables of the caregivers entered into the regression analyses were age 
and gender, of which only caregivers’ gender had significant impact on the caregivers’ 
anxiety. Female caregivers report higher anxiety level than men, a finding that is supported by 
several studies (Hagedoorn et al., 2002; Grov et al., 2005; Goldzweig et al., 2009). For 
oncology nurses it seems important to have in mind female caregivers’ expression of a higher 
level of anxiety when helping caregivers of cancer patients.  
  Clinical variables included in the regression analysis were palliative and curative phase, 
vomiting and trouble sleeping, where only the latter mentioned variable revealed significant 
impact on the caregivers’ depression. An explanation may be related to the fact that for 
patients that have trouble sleeping the caregivers interpret such sign as patients’ concerns. Our 
finding is in accordance with the study performed by Carter and Chang (2000), where they 
found that 64% of caregivers’ depression was predicted by sleep problems in the patients. 
From a clinical point of view we recommend oncology nurses to highlight patients’ problems 
with insomnia as this symptom may be important for caregivers’ mental health. We have no 
data on the caregivers’ eventually problems with sleep related symptoms, and therefore 
further research should focus on such aspects in caregivers as insomnia and mental health is 
shown to be highly correlated in a large Norwegian survey (Neckelmann et al., 2007; 
Sivertsen et al., 2009). 
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The limitations in this study reflect the abovementioned statement that we have not 
included instruments covering phenomenon that may be important for caregivers’ mental 
health and QOL, e.g. sleeping problems. Patients in this study represent a large time span of 
the disease journey and maybe patients’ symptoms affect their caregivers more in the terminal 
stage? Further research is recommended to explore this more closely. This study lacks 
information regarding the cancer patients’ medical treatment. As treatment may have great 
impact on symptom burden in the patients, such data should be incorporated in future 
research. In addition to treatment having impact on symptoms, the symptoms may vary from 
one day to another. There is a need for more longitudinal data to capture this kind of variation.   
Even though we used two different samples of family caregivers to increase the 
sample size, the sample size, especially in the curative phase is small and low statistical power 
and risk for type II statistical error may be present.  
However, bringing into a study well-documented and psychometric tested instruments 
as the SF-36, the HADS, and variables from the EORTC give basis for valuable insight into 
these aspects for this particular sample-groups. 
Conclusion  
This study showed that trouble sleeping in cancer patients, regardless of the disease stage, has 
significant impact on the caregivers’ mental health. Additionally, female caregivers seem 
more vulnerable than male caregivers for higher level of anxiety. The mental dimension of the 
QOL for caregivers is affected by the patients’ age, where younger patients have greater 
impact on caregivers’ mental QOL. Oncology nurses are to pay attention to the patient’s 
trouble sleeping as an indicator for caregivers’ experience of their mental health. 
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Table 1 – Demographic and clinical characteristics of the total sample and among the 
two patient groups  
Characteristics Total 
Sample 
N=159 
 
Palliative 
phase 
n=127 
Curative 
phase 
n=32 
P-value 
Age, mean (SD) 58.6 (11.3) 60.0 (10.9) 52.3 (10.2) .001 
Gender, n (%) 
Men 
Women 
 
50 (31) 
109 (69) 
 
43 (34) 
84 (66) 
 
7 (22) 
25 (78) 
 
.19 
Education, n (%) 
Primary school 
Secondary school 
College/university 
 
35 (23) 
59 (38) 
61 (39) 
 
34 (27) 
43 (35) 
47 (38) 
 
1 (3) 
16 (52) 
14 (45) 
 
.01 
Employment status, n (%)   
Not working 
Working full/part time 
 
136 (87) 
21 (13) 
 
110 (88) 
15 (12) 
 
26 (81) 
6 (19) 
 
.32 
Function, n (%) 
High function 
Impaired 
 
103 (65) 
56 (35) 
 
80 (63) 
47 (37)  
 
23 (72) 
9 (28) 
 
.35 
Cancer diagnosis, n (%) 
Breast 
Prostate 
Gynecologic 
Colorectal  
Other 
 
74 (46) 
29 (18) 
7 (5) 
20 (13) 
29 (18) 
 
61 (49) 
28 (22) 
4 (3) 
17 (13) 
17(13) 
 
13 (41) 
1 (3) 
3 (9) 
3 (9) 
12 (38) 
 
.003 
Metastases, n (%) 
Yes 
No 
 
129 (81) 
30 (19) 
 
124 (98) 
3 (2) 
 
5 (16) 
27 (84) 
 
.001 
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Table 2 – Demographic characteristics of the caregivers of the two patients groups   
 
Characteristic Total sample 
Caregivers 
N=159 
Palliative 
phase 
n=127 
Curative 
phase  
n= 32 
P- value 
Age, mean (SD) 57 (12.3) 57.7 (12.1) 52.2 (11.3) .002 
Gender, n (%) 
Men 
Women 
 
102 (61) 
65 (39) 
 
70 (55) 
57 (45) 
 
32 (80) 
8 (20) 
 
.005 
Relation to patient 
Married 
Daughter/ son 
Friend 
Sibling 
 
140 (89) 
7 (4) 
9 (6) 
1(1) 
 
109 (87) 
7 (6) 
8 (6) 
1 (1) 
 
31 (97) 
0 (0) 
1 (3) 
0 (0) 
 
.43 
Education, n (%) 
Primary school 
Secondary school 
College/university 
 
37 (23) 
62 (38) 
65 (40) 
 
29 (24) 
45 (36) 
50 (40) 
 
8 (29) 
17 (43) 
15 (38) 
 
.77 
Employment status, n (%) 
Not working 
Working full/part time 
 
77 (47) 
88 (53) 
 
62 (50) 
63 (50) 
 
15 (38) 
25 (62) 
 
.18 
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Table 3 – Comparisons of symptoms between cancer patients in the palliative and the 
curative phase   
Characteristic 
Scoring range:  
1-4 
All patients 
(N=159) 
Palliative phase 
(n= 127) 
mean (SD) 
Curative phase 
(n= 32) 
mean (SD) 
T-test 
P-value 
Need to rest 2.85 (.83) 2.90 (.82)         2.66(.87) .15 
Pain  2.70 (.88) 2.66 (.91) 2.84 (.77) .31 
Tired 2.68 (.84) 2.66 (.84) 2.75 (.80) .57 
Felt weak 2.64 (.86) 2.68 (.86) 2.53 (.84) .37 
Lack of appetite  2.04 (1.03) 2.05 (1.0) 1.88 (.94) .39 
Trouble sleeping 2.02 (.97) 1.97 (.92) 2.34 (1.2) .05 
Constipated  1.98 (1.03)  2.02 (1.03) 1.84 (1.0) .40 
Short of breath  1.81 (1.01) 1.86 (1.0) 1.63 (.94) .24 
Nausea 1.80 (.93) 1.85(.96) 1.59 (.80) .17 
Diarrhea 1.51 (.73) 1.52 (.72) 1.50 (.84) .91 
Vomited 1.32 (.69) 1.38 (.74) 1.09 (.39) .03 
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Table 4 - Linear regression analyses with physical and mental QOL, anxiety and 
depression as dependent variables 
 Std. β t P-value 
PCS  
Patient:      Age 
      Vomiting  
      Trouble sleeping 
      Curative/palliative phase 
Caregiver: Gender 
      Age 
 
-0.07 
0.01 
0.06 
0.03 
0.05 
-0.23 
 
-0.52 
0.14 
0.65 
0.29 
0.48 
-1.86 
 
0.61 
0.89 
0.52 
0.77 
0.64 
0.06 
MCS  
Patient:      Age 
      Vomiting  
      Trouble sleeping 
      Curative/palliative phase 
Caregiver: Gender 
      Age 
 
0.30 
-0.10 
0.00 
-0.03 
0.17 
-0.09 
 
2.12 
-1.17 
0.00 
-0.32 
1.61 
-0.68 
 
0.04 
0.24 
1.00 
0.75 
0.11 
0.50 
HADS-A 
Patient:      Age 
      Vomiting  
      Trouble sleeping 
      Curative/palliative phase 
Caregiver: Gender 
      Age 
 
-0.25 
0.08 
0.16 
0.05 
-0.21 
0.23 
 
-1.77 
0.94 
1.87 
0.59 
-2.08 
1.80 
 
0.08 
0.35 
0.07 
0.56 
0.04 
0.07 
HADS-D 
Patient:      Age 
      Vomiting  
      Trouble sleeping 
      Curative/palliative phase 
Caregiver: Gender 
      Age 
 
-0.19 
0.08 
0.17 
0.03 
-0.08 
0.18 
 
-1.33 
0.93 
1.97 
0.34 
-0.83 
1.45 
 
0.19 
0.37 
0.05 
0.74 
0.41 
0.15 
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